Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol

Fig. 4

2 × 2 contingency table illustrating McNemar’s test for paired data to assess rates of change for the biomarker test, ArteraAI Prostate Test, on shared ADT decision making. Primary endpoint of proportion changing shared decision on use of ADT is calculated as (b + c) / (a + b + c + d)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us